MedPath

RELAX: A Mobile Application Suite Targeting Obesity and Stress

Not Applicable
Completed
Conditions
Weight
Stress
Registration Number
NCT02615171
Lead Sponsor
University of Connecticut
Brief Summary

This research is being done is to evaluate the feasibility and acceptability of a novel weight loss mobile app that was designed to be less burdensome than traditional weight loss apps.

Detailed Description

Obesity and stress are highly comorbid and both increase risk for cardiovascular disease (CVD). Stress is associated with disinhibited eating, junk food consumption and low consumption of produce and whole grains. Both stress and stress-induced eating are not only associated with obesity but also predict worst outcomes in lifestyle interventions. Stress and stress-induced eating should be targeted in interventions to maximize weight loss; however, this makes for a very intensive intervention. Technology could be leveraged to reduce intervention burden.

In this trial investigators propose to compare the feasibility, usability, acceptability, and burden of an traditional weight loss app that includes diet and physical activity self-monitoring features to an app (Slip Buddy) we developed that focuses on self-monitoring of stress eating. With Slip Buddy, the user is just asked to track overeating episodes, indicating when they are triggered by stress. The majority of weight loss apps are burdensome to users by requiring them to self-monitor diet and exercise. They also ignore major barriers to weight loss, such as stress. This work moves the field forward by addressing user burden and an important barrier to weight loss.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
64
Inclusion Criteria
  • Have a BMI of 27-45
  • Currently use an Android smartphone
  • Have cell phone connectivity at home and work
  • Uses a smartphone every day
Exclusion Criteria
  • Under the age of 18 and over the age of 65;
  • BMI under 27 or over 45;
  • Not interested in losing weight;
  • Does not currently own a smartphone;
  • Smartphone type and/or version not meeting app requirements;
  • No phone connectivity at home and work;
  • Unable to walk unaided for ¼ mile without stopping;
  • Has a condition that precludes dietary changes (i.e. ulcerative colitis, Crohn's disease, active diverticulitis, renal disease);
  • On a medication affecting weight;
  • Type 1 or 2 diabetes;
  • Had gastric bypass surgery;
  • Had or plans to have gastric bypass surgery during the study period;
  • Pregnant/lactating;
  • Has bipolar disorder, substance abuse, bulimia, or severe depression;
  • Lost 5% or more body weight in the last 3 months;
  • Has not experienced emotional eating over the last week;
  • On medication affecting weight;
  • Has concerns about being audiotaped;
  • Prisoner;
  • Unable to provide consent; or
  • Non-English speaking

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Usability12 weeks

Usability will be assessed using the System Usability Scale (SUS), a 10-item measure with 5-point Likert scale response options (Strongly Agree to Strongly Disagree). Scores are summed (0-40) then converted to a 0-100 scale, with higher scores indicating higher usability. Scores above 58 are considered above average, and scores above 80 are considered to indicate high usability where participants are likely to recommend the product to friends.

Burden12 weeks

At 12 weeks, participants were asked how burdensome the task of using their assigned application was on a scale of 0-100, 0 being not at all burdensome and 100 being very burdensome.

Percentage of Days App Used Over 12 Weeks12 weeks

App use was measured for each condition using either backend data from Slip Buddy or reviewing MyFitnessPal entries indicating use over each 24-hour period.

Acceptability12 weeks

Acceptability was assessed with a single item at 12 weeks assessing perceived helpfulness of the assigned app: "Tracking my diet and exercise with MFP/slips with Slip Buddy was helpful" (responses on a 5-point Likert scale from strongly disagree to strongly agree). Acceptability was indicated by responses of agree or strongly agree.

Secondary Outcome Measures
NameTimeMethod
Percent Weight Change From Baseline to 12-Week Follow-Up12 weeks

A digital scale (Fitbit Aria) will be used to record weight. Percent weight change was calculated using weight at baseline and weight at 12-week follow-up. Missing values were calculated using last carry forward (LOCF).

Change in Emotional Eating From Baseline to 12-Week Follow-Up12 weeks

Three-Factory Eating Inventory is an 18-item measure and the emotional eating subscale consists of 3 items on a 4-point Likert scale. The score is derived by a multi-step equation. The range of scores for this subscale is 0-100, higher scores indicate higher emotional eating.

Change in Perceived Stress From Baseline to 12-Week Follow-Up12 weeks

The Perceived Stress Scale is a 14-item measure of perceived stress. Scores range from 0-56, higher scores indicate higher perceived stress.

Trial Locations

Locations (1)

University of Connecticut

🇺🇸

Storrs, Connecticut, United States

© Copyright 2025. All Rights Reserved by MedPath